These data indicate that the CPVT-associated G357S mutation enhances the arrhythmogenic SOICR and reduces RyR2 protein expression, which may be attributable to the incomplete penetrance of CPVT in this family. Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia.